CLF065 for Chronic Pouchitis

• Status: NOT_YET_RECRUITING
• Trial end date: 2027-06-01

Summary

This clinical trial is to evaluate investigational compound CLF065 as a treatment for adult patients with chronic pouchitis. The goals are to establish the safety, feasibility and efficacy of weekly dosing of long acting CLF065 versus placebo.

• Phase: PHASE2

Details

• Lead Sponsor: Calibr, a division of Scripps Research